## Clinical Presentation This patient has a bleeding duodenal ulcer (melena, anemia, hemodynamic changes) with high-risk endoscopic stigmata (visible vessel, adherent clot). The Forrest classification places this ulcer at Forrest IIa–IIb (high rebleeding risk ~40% without intervention). ## Management Strategy **Key Point:** High-risk bleeding peptic ulcers require DUAL therapy: (1) endoscopic hemostasis and (2) high-dose PPI to maintain intragastric pH > 6 for clot stabilization. **High-Yield:** Visible vessels and adherent clots are indications for endoscopic intervention (injection, thermal coagulation, or mechanical hemostasis). PPI monotherapy is insufficient for Forrest IIa–IIb ulcers. ### Correct Management Sequence 1. **Endoscopic hemostasis** — inject epinephrine + sclerosant or apply thermal coagulation to the visible vessel 2. **High-dose IV PPI** — omeprazole 40 mg IV bolus, then 40 mg IV infusion over 24 hours (or pantoprazole 80 mg IV bolus + 8 mg/hr infusion) to suppress gastric acid and stabilize clot 3. **H. pylori eradication** — triple or quadruple therapy (PPI + clarithromycin + amoxicillin ± metronidazole) for 14 days 4. **Supportive care** — IV fluids, blood transfusion if Hb < 7 g/dL or ongoing bleeding **Clinical Pearl:** IV PPI dosing is critical in bleeding ulcers. Oral PPI alone (even high-dose) does not achieve rapid pH elevation needed to prevent rebleeding in the first 24–72 hours after endoscopy. ## Why This Patient Needs Immediate Intervention | Feature | Risk Level | |---------|------------| | Visible vessel | High | | Adherent clot | High | | Melena + Hb drop | Active/recent bleeding | | H. pylori positive | Eradication required | **Mnemonic:** **VISIBLE = Very Important — Seek Immediate Bleeding Lesion Endoscopy** — any Forrest I or IIa ulcer requires urgent endoscopic therapy. [cite:Harrison 21e Ch 297]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.